Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
“We are entering an extremely exciting phase in the company’s life – delivering medical-grade features to our users at scale. We know there is a huge need and appetite for trustworthy products in this space and we are taking a lot of care to do this right.” Clue Co-CEO Carrie Walter. Image: Clue
Highlights
Clue adds €16M in funding to support the roll-out of Clue Birth Control, its FDA-cleared digital contraceptive.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
